FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a ...
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a ...
ENT & Allergy – 2024 Update: Conservative Pace Continues
Summary Private equity-backed Physician Practice Management (“PPM”) companies in ...
Ophthalmology – 2024 Update: Entering a Mature Stage
Summary Private equity’s investments in ophthalmology are entering a ...
Ophthalmology 2024 Update
Private equity’s investments in ophthalmology are entering a new, more ...
FOCUS Investment Banking Represents Michigan ENT and Allergy Specialists in its Partnership with Parallel ENT and Allergy
Washington, DC, (November 30, 2023) – FOCUS Investment Banking (“FOCUS”), ...
How to Manage Risks When Selling Your Physician Practice
Based on the large number of medical practices acquired over ...
What is the Value of my Medical Practice?
This article focuses on how medical practices are valued by ...
FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023
Washington, DC, (July 27, 2023) – FOCUS Investment Banking (“FOCUS”) ...
ENT & Allergy Practices Attract Private Equity
Armed with anywhere between $2 trillion and $4 trillion of ...
